Posted on 5/23/18
Rare Disease Report Expands Strategic Alliance Partnership with Lowe Syndrome Association
CRANBURY, N.J.--(BUSINESS WIRE)--Rare Disease Report® (RDR®), a digital component of Rare Disease Communications®, adds the Lowe Syndrome Association (LSA) to the Strategic Alliance Partnership program, announced . . .
Posted on 5/22/18
Celgene: Still (Looks) Appealing
Celgene (CELG) has been on my watchlist for a while as its shares continue to lag despite the promise of a rich pipeline, high regard of . . .
Posted on 5/22/18
Johnson & Johnson (JNJ) Presents at UBS Health Care Brokers Conference (Transcript)
Johnson & Johnson (NYSE:JNJ) UBS Health Care Conference May 21, 2018 10:00 AM ETExecutivesMatt Stuckley - IRSandra Peterson - Executive VP & Group Worldwide ChairmanAnalystsVikramjeet Chopra . . .
Posted on 5/22/18
CURE Magazine Names the 2018 Bone Health Champions
CRANBURY, N.J.--(BUSINESS WIRE)--CURE®magazine, the nation’s leading consumer digital and print media enterprise focused entirely on patients with cancer, recognized four nurses as the 2018 Bone Health . . .
Posted on 5/21/18
J&J Gets Rid Of Drug For Alzheimer's, But Remains Strong With Oncology Business
Recently, Johnson & Johnson (JNJ) announced that it would axe its Alzheimer's drug atabecestat. This move is another blow to a pharmaceutical company seeking to find . . .
Posted on 5/21/18
Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?
Warren Buffett's famous for telling investors to be greedy when others are fearful, but buying Teva Pharmaceuticals Industries (NYSE:TEVA) last year seemed like searching for loose . . .
Posted on 5/18/18
Boston Medical Center Wins ECRI Institute's Award for Pulmonary Care App
ECRI Institute is pleased to announce that Boston Medical Center is the winner of the 2018 Health Devices Achievement Award. The award, now in its 12th . . .
Posted on 5/17/18
Johnson & Johnson (JNJ) Investor Presentation - Slideshow
The following slide deck was published by Johnson & Johnson in conjunction with this event.READ FULL ARTICLE HERE
Posted on 5/17/18
Generic Revlimid Could Sink Celgene
Blow ups in its Celgene's (CELG) R&D pipeline have caused bulls to question the company's future growth. Generic drug makers could now pose challenges to Revlimid, . . .
Posted on 5/17/18
Celgene's (CELG) Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)
Celgene Corporation (NASDAQ:CELG) Bank of America Merrill Lynch Healthcare Conference Call May 16, 2018 1:00 PM ETExecutivesPeter Kellogg - Chief Financial OfficerAnalystsYing Huang - Bank of . . .
Posted on 5/17/18
Teva's Generic Restasis Could Punish Allergan
Source: newswire.caLast week Teva (TEVA) announced it had launched a generic version of Allergan's (AGN) blockbuster dry-eye drug Restasis in Canada: Teva Canada Limited, a subsidiary . . .
Posted on 5/16/18
What Can I Expect To Make If I Invest In Johnson & Johnson Today?
OverviewAAA rated Johnson & Johnson (NYSE:JNJ) has produced one of the most impeccable and consistent long-term records of fundamental results and growth. No matter whether you . . .
Posted on 5/15/18
MTBC Reports First Quarter 2018 Results
SOMERSET, N.J , May 15, 2018 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced . . .
Posted on 5/15/18
Cel-Sci: Simple Math Appears To Imply Phase 3 Success
Cel-Sci Corporation is currently testing Multikine (Leukocyte Interleukin) as a potential first-line therapy in patients with squamous cell carcinoma of the head and neck. Head and . . .
Posted on 5/15/18
Celgene Starts the Year With a Bang
Celgene (NASDAQ:CELG) started the year off with a solid first quarter, leading management to raise its 2018 guidance already.Celgene results: The raw numbers MetricQ1 2018Q1 2017Year-Over-Year . . .
Posted on 5/15/18
Oncobiologics Announces $15 Million Private Placement Offering
CRANBURY, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that on May 11, 2018, it entered into a purchase agreement . . .
Posted on 5/14/18
Pharmacy Times Named Industry News Provider of the Year by American Pharmacy Purchasing Alliance
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading media resource for pharmacists and the pharmacy industry, has been named the 2018 Industry News Provider of the Year by . . .
Posted on 5/11/18
Zelis Healthcare and MD Insider Announce Partnership
BEDMINSTER, N.J. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Zelis Healthcare, a market-leading healthcare technology company, today announced a strategic partnership with MD Insider to enhance network analytics capabilities . . .
Posted on 5/10/18
Bellerophon Provides Business Update
WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and . . .
Posted on 5/10/18
Ortho Clinical Diagnostics in India Recognized as a 'Great Place to Work'
Ortho Clinical Diagnostics India has been certified as a Great Place to Work by the Great Place to Work® Institute, India.The rigorous assessment required to become . . .
Posted on 5/10/18
Immunomedics Provides Corporate Update
MORRIS PLAINS, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU), a science-based and innovation-focused biopharmaceutical company committed to the development and worldwide commercialization of . . .
Posted on 5/9/18
Recro Pharma Reports First Quarter 2018 Financial Results
MALVERN, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 5/9/18
Idera Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
EXTON, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic . . .
Posted on 5/9/18
PANTHERx Specialty Pharmacy Wins Patient Choice Award
PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, has been named the winner of the Specialty Pharmacy Patient Choice Award™ for the non-PBM/payer category. This is . . .
Posted on 5/9/18
Ascendia Pharmaceuticals Announces Product Development Collaboration with KC Pharmaceuticals
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, formulation, and manufacture of poorly soluble molecules, today announced that it has entered . . .

